EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting atrial fibrillation after an acute coronary syndrome: insights from the BACS & BAMI study

Jaime Francisco Larre-Guerra, Álvaro Castrillo-Capilla, Macarena Garbayo-Bugeda, Andrea Kallmeyer, Ester Cánovas, María Nieves Tarín, Carmen Cristóbal, Ana Huelmos, Carlos Gutiérrez-Landaluce, José Antonio Esteban Chapel, Junior Senra, María Luisa González Casaus und 6 weitere

Clinical Research in Cardiology · 20.04.2026

DOI: 10.1007/s00392-026-02898-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Research in Cardiology, online erschienen am 20.04.2026. Verfasst von Jaime Francisco Larre-Guerra und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, IIS-Fundación Jiménez Díaz, 28040, Madrid, Spain. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Commission, Sociedad Española de Cardiología.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation (AF) is among the most prevalent arrhythmias. Its onset after an acute coronary syndrome (ACS) is especially notable given the high coronary disease burden. Mineral metabolism, particularly fibroblast growth factor 23 (FGF23), has been linked to cardiovascular outcomes. This study examines whether FGF23, related markers and other variables can predict AF occurrence after an ACS, considering age differences.

Methods

Data were obtained from the BACS & BAMI study, including 1189 patients from five Madrid hospitals. Baseline clinical characteristics and laboratory results were recorded. Patients were monitored annually through clinical appointments. Univariate and multivariate Cox analyses were conducted separately for patients aged ≤ 65 and > 65 years, based on CHA2DS2-VA thromboembolic score.

Results

Over a follow-up of 5.44 (3.03–7.46) years, 5.5% of patients developed AF. In those ≤ 65 years, FGF23 was an independent predictor of the development of AF (HR 1.37 [1.04, 1.79] per 100-unit rise; p = 0.026). Among patients > 65 years, a history of stroke was associated with a heightened risk (HR 2.75 [1.03, 7.34]; p = 0.044), while beta-blocker therapy appeared to be protective (HR 0.42 [0.23, 0.78]; p = 0.007). Previous AF consistently forecasted recurrence across both groups (HR 11.3 [2.92, 43.6]; p = 0.002 and HR 6.41 [3.13, 13.1]; p < 0.001, respectively).

Conclusions

FGF23 seems to be an independent and positive predictor of AF after an ACS in patients ≤ 65 years, whereas in older individuals, beta‐blocker therapy emerges as a potential protective measure. These insights may enhance current risk models with age-specific adjustments and encourage more tailored clinical strategies in post-ACS patients. Graphical Abstract

Schlagwörter

Stichwörter der Autor:innen

Acute coronary syndromeAtrial fibrillationBeta-blockersFibroblast growth factor 23

Autor:innen und Institutionen

  • Department of Cardiology, IIS-Fundación Jiménez Díaz, 28040, Madrid, Spain.
  • Faculty of Medicine, Universidad Autónoma de Madrid, 28029, Madrid, Spain.
  • Department of Cardiology, Hospital Universitario de Móstoles, 28935, Madrid, Spain.
  • Faculty of Medicine, Universidad Rey Juan Carlos, 28922, Alcorcón, Madrid, Spain.
  • Department of Cardiology, Hospital Universitario de Fuenlabrada, 28942, Madrid, Spain.
  • Department of Cardiology, Hospital Universitario Fundación Alcorcón, 28922, Madrid, Spain.

Förderung

  • Instituto de Salud Carlos III
  • European Commission
  • Sociedad Española de Cardiología
  • Ministerio de Agricultura, Alimentación y Medio Ambiente
  • Universidad Autónoma de Madrid

Zitieren

APA

Larre-Guerra, J. F., Castrillo-Capilla, Á., Garbayo-Bugeda, M., Kallmeyer, A., Cánovas, E., Tarín, M. N., Cristóbal, C., Huelmos, A., Gutiérrez-Landaluce, C., Chapel, J. A. E., Senra, J., González Casaus, M. L., Alonso, J., López-Bescós, L., Mahíllo, I., Lorenzo, Ó., Rubio-Campal, J. M., & Tuñón, J. (2026). Predicting atrial fibrillation after an acute coronary syndrome: insights from the BACS & BAMI study. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-026-02898-3

Vancouver

Larre-Guerra JF, Castrillo-Capilla Á, Garbayo-Bugeda M, Kallmeyer A, Cánovas E, Tarín MN, et al. Predicting atrial fibrillation after an acute coronary syndrome: insights from the BACS & BAMI study. Clinical Research in Cardiology. 2026. doi:10.1007/s00392-026-02898-3

BibTeX
@article{LarreGuerra2026,
  author = {Larre-Guerra, Jaime Francisco and Castrillo-Capilla, Álvaro and Garbayo-Bugeda, Macarena and Kallmeyer, Andrea and Cánovas, Ester and Tarín, María Nieves and Cristóbal, Carmen and Huelmos, Ana and Gutiérrez-Landaluce, Carlos and Chapel, José Antonio Esteban and Senra, Junior and González Casaus, María Luisa and Alonso, Joaquín and López-Bescós, Lorenzo and Mahíllo, Ignacio and Lorenzo, Óscar and Rubio-Campal, José Manuel and Tuñón, José},
  title = {Predicting atrial fibrillation after an acute coronary syndrome: insights from the BACS & BAMI study},
  journal = {Clinical Research in Cardiology},
  year = {2026},
  doi = {10.1007/s00392-026-02898-3}
}
Kostenlos starten →